(firstQuint)iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications.

 The purpose of this study is to evaluate the intraocular pressure (IOP) lowering effect of iStent inject in eyes of subjects with primary open-angle glaucoma previously on two anti-glaucoma medications.

 Outcomes will be evaluated at 12 and 24 months.

.

 iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications@highlight

The purpose of this study is to evaluate the intraocular pressure (IOP) lowering effect of iStent inject in eyes of subjects with primary open-angle glaucoma previously on two anti-glaucoma medications.

